Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients
This study has been terminated.
( New treatments available, which prevents additional recruitment. )
Study NCT01567540   Information provided by Institut National de la Santé Et de la Recherche Médicale, France

First Received on March 2, 2012.   Last Updated on January 17, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial